Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

Johannis A. van Rossum; Marieke A. D. Peters; Paul van der Valk; Brigit A. de Jong

doi:https://doi.org/10.1016/j.msard.2019.06.006

Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

Johannis A. van Rossum, Marieke A. D. Peters, Paul van der Valk, Brigit A. de Jong

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	38-40
Number of pages	3
Journal	Multiple Sclerosis and Related Disorders
Volume	34
DOIs	https://doi.org/10.1016/j.msard.2019.06.006
Publication status	Published - Sept 2019

Keywords

Cutaneous adverse event
Daclizumab
Multiple sclerosis

Access to Document

https://doi.org/10.1016/j.msard.2019.06.006

Cite this

@article{23c6c0b5addf4e34a736d794463a21b3,

title = "Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient",

keywords = "Cutaneous adverse event, Daclizumab, Multiple sclerosis",

author = "{van Rossum}, {Johannis A.} and Peters, {Marieke A. D.} and {van der Valk}, Paul and {de Jong}, {Brigit A.}",

year = "2019",

month = sep,

doi = "https://doi.org/10.1016/j.msard.2019.06.006",

language = "English",

volume = "34",

pages = "38--40",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier",

}

TY - JOUR

T1 - Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

AU - van Rossum, Johannis A.

AU - Peters, Marieke A. D.

AU - van der Valk, Paul

AU - de Jong, Brigit A.

PY - 2019/9

Y1 - 2019/9

KW - Cutaneous adverse event

KW - Daclizumab

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85067385334&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.msard.2019.06.006

DO - https://doi.org/10.1016/j.msard.2019.06.006

M3 - Letter

C2 - 31228714

SN - 2211-0348

VL - 34

SP - 38

EP - 40

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

ER -

Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

Keywords

Access to Document

Other files and links

Cite this